Protein interaction research maps how proteins associate, form complexes, transmit signals, regulate pathways, and organize cellular systems across health, disease, and therapeutic response.
Protein interactions are essential for cellular function because proteins rarely act alone. They assemble into complexes, regulate signaling pathways, control gene expression, coordinate metabolism, and shape the molecular networks that sustain life.
At PanorOmics, protein interactions are presented as a core proteomics research area: a systems-level framework for understanding pathway organization, disease mechanisms, biomarker discovery, therapeutic targeting, and multi-omics network biology.
Identifying physical and functional interactions among proteins to understand molecular complexes, signaling pathways, and cellular organization.
Studying how interacting proteins form biological networks that regulate cellular processes, disease mechanisms, and therapeutic response.
Characterizing multi-protein assemblies that coordinate transcription, metabolism, signaling, DNA repair, and cellular structure.
Analyzing disrupted protein interaction networks associated with cancer, neurodegeneration, immune disease, infection, and therapeutic resistance.
Combines protein enrichment with mass spectrometry to identify interacting partners and protein complexes.
Detects direct protein–protein interactions using genetic reporter systems.
Experimental method used to test whether proteins associate within biological samples.
Approaches such as BioID and APEX label nearby proteins to map interaction environments in living cells.
AI and network-based methods used to predict protein interactions, complexes, and functional relationships.
Direct or indirect molecular associations between proteins within cells or biological systems.
Groups of proteins that assemble into functional molecular machines.
Protein interaction pathways that transmit biological signals and regulate cellular responses.
Mapping altered protein interactions that contribute to disease mechanisms and therapeutic resistance.
Large-scale mapping of protein interaction networks across cells, tissues, organisms, or disease states.
Combines protein interaction data with genomics, transcriptomics, proteomics, metabolomics, and clinical data.
Related proteomic approaches such as protein identification, mass spectrometry, and biomarker discovery are explored across the Proteomics Research Center.
Experimental approaches such as co-immunoprecipitation and yeast two-hybrid screening helped establish systematic protein interaction analysis.
Large-scale studies began mapping protein interaction networks across organisms and biological systems.
AP-MS enabled high-throughput identification of protein complexes and interaction partners in biological samples.
Protein interaction data became central to pathway analysis, systems biology, disease network modeling, and functional interpretation.
BioID, APEX, and related methods expanded interaction mapping by capturing protein neighborhoods inside living cells.
Protein interaction networks increasingly support research into cancer, neurodegeneration, immune disease, infection, and drug response.
AI increasingly supports protein interaction prediction, complex modeling, network interpretation, and therapeutic target discovery.
Continue exploring the Proteomics Research Center.
Continue exploring the Proteomics Research Center.
Continue exploring the Proteomics Research Center.